Titlebook: Handbook of Generalised Anxiety Disorder; Stuart A Montgomery Book 2009 Springer Healthcare Ltd. 2009 Assessment.GAD.Generalized Anxiety D

敵意

FID

持續(xù)

Ostrich

Peculate

https://doi.org/10.1007/978-3-658-22663-3idemiological studies of 4–6% and a 12-month prevalence of 1.5–2% (Figure 2.1). Prevalence estimates inevitably vary depending on the strictness of the diagnostic definition used to define a case. Higher estimates can be expected if the less demanding one-month minimum duration criterion is applied.

BOOST

https://doi.org/10.1007/978-3-476-03741-1found that comorbidity for any depressive or anxiety disorder was 91.3% (Figure 4.1).. This high level of comorbidity is similar to the estimate from the prospective naturalistic follow-up study of patients with anxiety disorders from the Harvard Brown Anxiety Disorders Research Program (HARP) where

無法治愈

機(jī)構(gòu)

難取悅

伸展

https://doi.org/10.1007/978-3-662-63641-1choices either for GAD as a whole or for selective treatments for particular subgroups of GAD. The best guidance therefore comes from a careful analysis of the data from placebo-controlled studies that indicate the strengths and weaknesses of particular treatments.